文献速递产科母胎医学

SARS-CoV-2感染孕妇的超声与多普勒表现:病例对照研究

Ultrasound and Doppler findings in pregnant women with SARS-CoV-2 infection.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-01-01

该回顾性病例对照研究比较了106例SARS-CoV-2阳性孕妇与103例匹配阴性对照的超声和多普勒表现,发现不良产前复合结局(APCO)无显著差异,但阳性组≤35周早产率更高(20.8% vs 8.7%,OR 2.73,95%CI 1.19-6.3,P=0.01),且糖尿病患病率更高(24.5% vs 12.6%,P=0.03)。

要点

  • SARS-CoV-2阳性孕妇的胎儿超声和多普勒异常与阴性对照无显著差异。
  • 阳性组≤35周早产风险显著增加(OR 2.73,95%CI 1.19-6.3)。
  • 阳性组糖尿病患病率更高,但子痫前期无显著差异。

核心结论

  • SARS-CoV-2阳性孕妇与阴性对照的胎儿超声及多普勒异常无显著差异。
  • SARS-CoV-2阳性孕妇≤35周早产率更高。

研究设计与样本

  • 对照组为103例按产妇年龄、产次、体重指数和孕周匹配的SARS-CoV-2阴性孕妇。

主要发现

  • 阳性组糖尿病患病率26/106(24.5%),对照组13/103(12.6%),P=0.03。
  • 阳性组子痫前期患病率21/106(19.8%),对照组11/103(10.7%),P=0.08。
  • 不良产前复合结局(APCO)阳性组19/106(17.9%),对照组9/103(8.7%),P=0.06。
  • 阳性组≤35周早产22/106(20.8%),对照组9/103(8.7%),OR 2.73(95%CI 1.19-6.3),P=0.01。

关键数值与推荐

  • APCO定义:小于胎龄儿、羊水过少、生物物理评分异常、多普勒测速异常或胎儿死亡中任一或多项。
  • 小于胎龄儿阳性组12/106(11.3%),对照组6/103(5.8%),P=0.17。
  • 多普勒评估异常阳性组8/106(7.5%),对照组2/103(1.9%),P=0.08。
  • 生物物理评分异常阳性组4/106(3.8%),对照组0/103(0%),P=0.14。
  • 阳性组发生2例胎儿死亡。

临床怎么用

  • 对SARS-CoV-2阳性孕妇应关注早产风险,尤其是≤35周早产。
  • 超声和多普勒检查可按常规指征进行,无需因SARS-CoV-2阳性而额外增加监测。
  • 需注意SARS-CoV-2阳性孕妇中糖尿病和肥胖的高发情况。

局限性

  • 回顾性研究设计可能引入选择偏倚和信息偏倚。
  • 样本量有限,可能不足以检测较小差异。
  • 研究期间为2020年早期,结论可能不适用于后续病毒变异株。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe and compare ultrasound and Doppler findings in pregnant women who were positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with findings in those who were SARS-CoV-2-negative, evaluated during the pandemic period. METHODS: In this retrospective case-control study, we analyzed data from 106 pregnant women who tested positive for SARS-CoV-2 at the time of, or within 1 week of, an ultrasound scan between 1 May and 31 August 2020. Scans were either performed for routine fetal evaluation or indicated due to a positive SARS-CoV-2 test. Forty-nine women were symptomatic and 57 were asymptomatic. For comparison, we analyzed data from 103 pregnant women matched for maternal age, parity, body mass index and gestational age at the time of the ultrasound scan. These control women did not report symptoms of SARS-CoV-2 infection at the time of the ultrasound scan or at the time of admission for delivery and had a negative SARS-CoV-2 test at admission for delivery. Fetal biometry, fetal anatomy, amniotic fluid volume and Doppler parameters, including umbilical and fetal middle cerebral artery pulsatility indices, cerebroplacental ratio and biophysical profile (BPP), were evaluated as indicated. Biometric and Doppler values were converted to Z-scores for comparison. Our primary outcome, an adverse prenatal composite outcome (APCO) included any one or more of: small-for-gestational-age (SGA) fetus, oligohydramnios, abnormal BPP, abnormal Doppler velocimetry and fetal death. Comorbidities, delivery information and neonatal outcome were compared between the two groups. RESULTS: Eighty-seven (82.1%) women who were positive for SARS-CoV-2 had a body mass index > 25 kg/m2 . SARS-CoV-2-positive women had a higher prevalence of diabetes (26/106 (24.5%) vs 13/103 (12.6%); P = 0.03), but not of pre-eclampsia (21/106 (19.8%) vs 11/103 (10.7%); P = 0.08), compared with controls. The prevalence of APCO was not significantly different between SARS-CoV-2-positive women (19/106 (17.9%)) and controls (9/103 (8.7%)) (P = 0.06). There were no differences between SARS-CoV-2-positive women and controls in the prevalence of SGA fetuses (12/106 (11.3%) vs 6/103 (5.8%); P = 0.17), fetuses with abnormal Doppler evaluation (8/106 (7.5%) vs 2/103 (1.9%); P = 0.08) and fetuses with abnormal BPP (4/106 (3.8%) vs 0/103 (0%); P = 0.14). There were two fetal deaths in women who were positive for SARS-CoV-2 and these women had a higher rate of preterm delivery ≤ 35 weeks of gestation (22/106 (20.8%) vs 9/103 (8.7%); odds ratio, 2.73 (95% CI, 1.19-6.3); P = 0.01) compared with controls. CONCLUSIONS: There were no significant differences in abnormal fetal ultrasound and Doppler findings observed between pregnant women who were positive for SARS-CoV-2 and controls. However, preterm delivery ≤ 35 weeks was more frequent among SARS-CoV-2-positive women. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Soto-Torres E, Hernandez-Andrade E, Huntley E, et al. Ultrasound and Doppler findings in pregnant women with SARS-CoV-2 infection. Ultrasound Obstet Gynecol. 2021. PMID: 33794060. doi:10.1002/uog.23642

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。